Literature DB >> 14651980

Effect of naturally occurring mutations in human glycine N-methyltransferase on activity and conformation.

Zigmund Luka1, Conrad Wagner.   

Abstract

Missense mutations in the enzyme, glycine N-methyltransferase (GNMT) have been shown to be one cause of persistent isolated hypermethioninaemia in humans. These mutations were first identified by metabolite analysis and were shown to be L49P, N140S, and H176N by gene sequencing. Here we report the kinetic and conformational characterization of the wild type and the three human mutant GNMTs expressed in Escherichia coli. Although quaternary, tertiary, and secondary structures of the mutant proteins are not changed, they are inactivated to different extents. The H176N mutation possesses 75% activity of the wild type enzyme while L49P has 10% activity and N140S has less than 0.5% activity of the wild type GNMT under the same conditions. All GNMTs display hyperbolic kinetics at neutral pH toward both substrates, S-adenosylmethionine and glycine. The turnover constants, k(cat) and Michaelis constants, K(m) for both substrates of all mutant proteins are considerably changed compared to the wild type enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651980     DOI: 10.1016/j.bbrc.2003.11.037

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma.

Authors:  Chia-Hung Yen; Yao-Cheng Lu; Chung-Hsien Li; Cheng-Ming Lee; Chia-Yen Chen; Ming-Yuan Cheng; Shiu-Feng Huang; Kuen-Feng Chen; Ann-Lii Cheng; Li-Ying Liao; Yan-Hwa Wu Lee; Yi-Ming Arthur Chen
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

2.  Mathematical modeling of the methionine cycle and transsulfuration pathway in individuals with autism spectrum disorder.

Authors:  Troy Vargason; Daniel P Howsmon; Stepan Melnyk; S Jill James; Juergen Hahn
Journal:  J Theor Biol       Date:  2016-12-29       Impact factor: 2.691

3.  Benzo[a]pyrene effects on glycine N-methyltransferase mRNA expression and enzyme activity in Fundulus heteroclitus embryos.

Authors:  Xiefan Fang; Wu Dong; Cammi Thornton; Kristine L Willett
Journal:  Aquat Toxicol       Date:  2010-02-06       Impact factor: 4.964

4.  Polymorphisms and disease: hotspots of inactivation in methyltransferases.

Authors:  Karen Rutherford; Valerie Daggett
Journal:  Trends Biochem Sci       Date:  2010-04-09       Impact factor: 13.807

5.  Destabilization of human glycine N-methyltransferase by H176N mutation.

Authors:  Zigmund Luka; Svetlana Pakhomova; Yury Luka; Marcia E Newcomer; Conrad Wagner
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

Review 6.  Glycine N-methyltransferase and regulation of S-adenosylmethionine levels.

Authors:  Zigmund Luka; S Harvey Mudd; Conrad Wagner
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

7.  Comparing Gut Microbiome in Mothers' Own Breast Milk- and Formula-Fed Moderate-Late Preterm Infants.

Authors:  Ziyi Wang; Achal Neupane; Richard Vo; Jessica White; Xiuqing Wang; Shin-Yi Lee Marzano
Journal:  Front Microbiol       Date:  2020-05-26       Impact factor: 5.640

8.  A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization.

Authors:  Suchandra DebRoy; Inga I Kramarenko; Sampa Ghose; Natalia V Oleinik; Sergey A Krupenko; Natalia I Krupenko
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

Review 9.  Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders.

Authors:  Ivo Barić; Christian Staufner; Persephone Augoustides-Savvopoulou; Yin-Hsiu Chien; Dries Dobbelaere; Sarah C Grünert; Thomas Opladen; Danijela Petković Ramadža; Bojana Rakić; Anna Wedell; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2016-09-26       Impact factor: 4.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.